Sudeep Pharma IPO Subscription Status
Sudeep Pharma IPO was subscribed 93.72 times when bidding closed on 25 Nov 2025: QIB 213.08x, NII 116.72x, Retail 15.65x.
The Sudeep Pharma IPO has been subscribed 93.72x times overall. Retail investors have shown interest with bids for 15.65x the shares available. The Non-Institutional Investor (NII) category has been subscribed 116.72x. Within NII, Big HNI (B-HNI) subscribed 134.91x and Small HNI (S-HNI) subscribed 80.33x. Qualified Institutional Buyers (QIBs) have subscribed 213.08x. Data last updated on 03 Sep, 02:08 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 21 Nov, 2025 and closes on 25 Nov, 2025. The shares are expected to list on stock exchanges on 28 Nov, 2025.
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of 30,18,550 38,141.08 Cr | 213.08x |
| NII | - of 22,63,913 15,669.46 Cr | 116.72x |
bHNI — bid amount above ₹10 Lakh |
- 12,074.65 Cr | 134.91 |
sHNI — bid amount ₹2–10 Lakh |
- 3,594.81 Cr | 80.33 |
| Retail | - of 52,82,463 4,902.41 Cr | 15.65x |
| TOTAL | - 28,85,745 applications 58,712.94 Cr | 93.72x |
Sudeep Pharma IPO Basis of Allotment
Final Final figures published by the registrar, after technical rejections. Allotment price ₹593.
| Category | AppsApplications | GotAllottees | Odds |
|---|---|---|---|
| TOTAL 65.56x subscribed | 28,85,745 | 2,17,991 | 1 out of 131 out of 13 |
Sudeep Pharma IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x, so retail allotment is by lottery. Going by the multiple alone, that is about 1 out of 15 (~6.4%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 213.08x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
25 Nov 2025
Day 3 |
93.71x | ▼ | |
|
QIB213.08x
BHNI-
SHNI-
Retail15.65x
|
|||
|
24 Nov 2025
Day 2 |
5.13x | ▼ | |
|
QIB0.13x
BHNI-
SHNI-
Retail5.02x
|
|||
|
21 Nov 2025
Day 1 |
1.43x | ▼ | |
|
QIB0.09x
BHNI-
SHNI-
Retail1.53x
|
|||
Sudeep Pharma IPO dates
From the bidding window to listing. Today is 23 November.
- Open 21 Nov 2025
- Close 25 Nov 2025
- Allotment 26 Nov 2025
- Refund/credit 27 Nov 2025
- Listing 28 Nov 2025
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Sudeep Pharma IPO?
As of IPO close date (25 Nov, 2025), the Sudeep Pharma IPO is subscribed 93.72x times. Retail category is 15.65x, and NII is 116.72x subscribed.
When is the allotment date for Sudeep Pharma IPO?
The allotment for Sudeep Pharma IPO is expected to be finalized on 26 November, 2025.
What is the GMP of Sudeep Pharma?
The Grey Market Premium (GMP) for Sudeep Pharma is currently ₹93, indicating a potential listing gain of 16%.
When will Sudeep Pharma IPO list on the stock market?
Sudeep Pharma is scheduled to list on BSE and NSE on 28 November, 2025.
What are the chances of getting allotment in Sudeep Pharma IPO?
The retail category is oversubscribed at 15.65x, meaning allotment is by lottery. Going by the multiple alone, that is about 1 out of 15 (~6.4%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 213.08x mean for Sudeep Pharma IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 213.08x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Sudeep Pharma IPO allotment status?
After the allotment date (26 Nov, 2025), you can check your Sudeep Pharma IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Sudeep Pharma IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.